LON:OPTI OptiBiotix Health (OPTI) Share Price, News & Analysis GBX 5.64 -0.01 (-0.21%) As of 10:10 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsInsider Trades About OptiBiotix Health Stock (LON:OPTI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get OptiBiotix Health alerts:Sign Up Key Stats Today's Range 5.50▼ 5.6450-Day Range 5.50▼ 6.5052-Week Range 4.50▼ 12.25Volume95,795 shsAverage Volume362,232 shsMarket Capitalization£5.82 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness. OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks. OptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes. This communication is a "Reach" announcement. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach. Read More Receive OPTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OptiBiotix Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OPTI Stock News HeadlinesOptiBiotix Health (LON:OPTI) Shares Pass Below Fifty Day Moving Average - Should You Sell?August 20 at 3:41 AM | americanbankingnews.comOptiBiotix Health (LON:OPTI) Shares Cross Below Fifty Day Moving Average - Time to Sell?August 12, 2026 | americanbankingnews.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.August 21 at 1:00 AM | Banyan Hill Publishing (Ad)Optibiotix Health Plc Share Price (OPTI.GB.PL)July 12, 2026 | lse.co.ukOptiBiotix Improves Revenue and Margins as Focus Shifts Toward Sustainable Profitability (OPTI)May 28, 2026 | uk.finance.yahoo.comOptiBiotix to Present Upgraded SweetBiotix Sugar Alternative at London Shareholder Event (OPTI)May 14, 2026 | uk.finance.yahoo.comOptiBiotix shares rise after company says it will not sell SkinBioTherapeutics stakeFebruary 17, 2026 | finance.yahoo.comOptiBiotix Health hails record start to 2026 after securing new ordersJanuary 21, 2026 | lse.co.ukSee More Headlines OPTI Stock Analysis - Frequently Asked Questions How have OPTI shares performed this year? OptiBiotix Health's stock was trading at GBX 6.61 on January 1st, 2026. Since then, OPTI shares have decreased by 14.7% and is now trading at GBX 5.64. How were OptiBiotix Health's earnings last quarter? OptiBiotix Health Plc (LON:OPTI) released its quarterly earnings data on Thursday, May, 28th. The company reported ($3.84) EPS for the quarter. The business earned $1.17 million during the quarter. OptiBiotix Health had a negative trailing twelve-month return on equity of 52.92% and a negative net margin of 333.62%. How do I buy shares of OptiBiotix Health? Shares of OPTI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of OptiBiotix Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that OptiBiotix Health investors own include SkinBioTherapeutics (SBTX), IQE (IQE), Oracle (ORCL), Digital Globe Services (DGS), Derwent London (DLN), Petrofac (PFC) and IP Group (IPO). Company Calendar Last Earnings5/28/2026Today8/21/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolLON:OPTI Previous SymbolLON:CMI CIKN/A Webwww.optibiotix.com Phone+44-20-79338780FaxN/AEmployees1Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (3.84) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£3.09 million Net Margins-333.62% Pretax MarginN/A Return on Equity-52.92% Return on Assets-13.93% Debt Debt-to-Equity RatioN/A Current Ratio4.27 Quick Ratio7.89 Sales & Book Value Annual Sales£1.17 million Price / Sales4.99 Cash FlowGBX 0.65 per share Price / Cash Flow8.68 Book ValueGBX 7.80 per share Price / Book0.72Miscellaneous Outstanding Shares103,300,000Free FloatN/AMarket Cap£5.82 million OptionableNot Optionable Beta1.82 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (LON:OPTI) was last updated on 8/21/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptiBiotix Health Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share OptiBiotix Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
